Devereaux Sellers, MD, MBA**

Undergraduate – Louisiana State University, Biology and Psychology

Graduate School – Davenport University, MBA in Healthcare Administration

Medical School – St. Matthew’s University School of Medicine

Residency – Pathology, The MetroHealth System/Case Western Reserve University

Faculty Appointment – Clinical Instructor of Pathology

Role in Fellowship Program – Alumnus 2023

Post Fellowship Position – Associate Director of Informatics, Pathology at The MetroHealth System (Cleveland, OH)

Brief Description – Dr. Sellers’ interests include digital pathology and using whole slide imaging and algorithms to assist with identifying certain cell populations, identifying disease/malignancy, and assessing immunohistochemical and special stains. His other interests include improving pathology workflows using the LIS system, patient outreach and advocacy, and how to bridge the gap between the pathologist and patient. Dr. Sellers has a passion for resident education, especially when it comes to the lost art of the autopsy. In his free time, he enjoys playing the drums, cooking out on the grill, and spending time with family.

Selected Recent Projects

Tracking patient follow-up after receiving a “positive for malignancy” biopsy result: There are two goals in this project; one is to look back and see how we have been doing with getting patients that fall into this category in for a follow-up visit with one of our oncology services. The second is to look into the future and see how many of the patients that fall into this category have scheduled a follow-up visit with one of our oncology services. The importance of looking ahead is that the patients that have not scheduled a follow-up are ones that we can reach out to and get them scheduled for a follow-up and help them get the care they need.

Looking at 10 years of GI biopsy data: Looking at 10 years of GI biopsy data in regards to high grade dysplasia, intramucosal carcinoma, and carcinoma in situ to look at GI management and patient outcomes as the entities that mention “carcinoma” are often treated like invasive cancer when they are not so the patient receives increased surveillance, surgery referrals, etc… when if completely removed during colonoscopy there is no theoretical risk of metastasis so they would not need increased surveillance or surgery.

* - Board Certified in Clinical Informatics
** - Board Eligible in Clinical Informatics